The 2013 membership survey highlighted that one of the main reasons members joined the Society was to keep up-to-date with developments in their field. To help support and facilitate this the Meetings Committee launched the following seven new Affinity Groups.
These groups will play a central role in encouraging networking and discussion between members, and encompass the areas previously defined by the Society’s Special Interest Groups.
What do the Affinity Groups do?
• Ensure all areas of pharmacology are well represented in Society activities
• Uphold the scientific quality of any BPS events relating to the Affinity Groups’ activities
• Facilitate networking and discussion amongst researchers within the area
• Recruit and review symposia proposals for, and assist in programme development of, the Society’s meetings' calendar
• Provide support for the abstract review process for the Society’s annual meeting
• Link with our journals with a view to providing content for themed issues and reviews
• Interact with other Learned Societies and funding bodies in the UK and overseas
• Deal with media enquiries and consultations
About each affinity group
Cardiovascular & Respiratory Pharmacology serves members with interests in all areas relevant to the cardiovascular and respiratory systems in health and disease including both experimental and clinical aspects from the molecular level, through to cellular, systems and whole-body approaches.
Drug Discovery, Development & Evaluation serves members with interests in all aspects from drug discovery to prescribed use including target identification, drug development, safety pharmacology, conduct of medical research and clinical trials, approval and licensing. This includes all areas of the drug discovery and development process including ‘omics approaches, drug-screening, molecular, cellular, systems or whole organism approaches, pharmacokinetics, pharmacodynamics, pharmacoepidemiology, pharmacoeconomics, clinical testing, drug regulation and registration, adverse drug reactions along with all aspects relevant to the post-market distribution and utilisation of drugs. Drug discovery also serves members with interests in natural products and nutraceuticals.
Education & Skills serves members with interests in all aspects of education related to pharmacology, toxicology, clinical pharmacology and therapeutics. This group brings together members engaged in, or who have an interest in, teaching undergraduate, postgraduate and professional learners, and enabling students to demonstrate competencies in relation to prescribing and to the safe and effective use of medicines.
Communicating pharmacology in the public domain is seen as another activity within this grouping.
Integrated & Systems Pharmacology serves members who study complex systems or take a whole animal approach to understand drug action or toxicity at molecular, cellular or organ system levels. Those working across several systems, or working in systems without a defined Affinity Group, might be expected to align with Integrated & Systems Pharmacology.
Molecular & Cellular Pharmacology serves members with interests that cover a broad range of molecular signalling pathways and cellular aspects relevant to pharmacology and which include basic biological processes and their dysfunction and pharmacological manipulation under pathophysiological conditions.
Neuropharmacology serves members with interests in all areas of neuroscience, neuropharmacology and neurotoxicology in health and disease including both experimental and clinical aspects from the molecular level, through cellular and systems to behavioural aspects. This includes, but is not limited to: molecular and cellular studies on brain cells or cells involved in supporting the nervous system; studies of the autonomic, peripheral and central nervous systems and the use and abuse of drugs influencing neuronal function at the molecular, cellular, systems or behavioural levels.
Toxicology serves members with interests in all aspects of toxicology, including (but not limited to) biological modelling, carcinogenesis, cardiovascular toxicology, clinical and translational toxicology, drug discovery toxicology, dermal toxicology, immunotoxicology, in vitro and alternative methods for toxicity evaluation, inhalation and respiratory, nanotoxicology, neurotoxicology, regulatory and safety evaluation, reproductive and developmental toxicology, risk assessment.
How do I join an Affinity Group?
All members are invited to join the Affinity Groups relevant to them – this can be more than one. In order to do so, once you have signed in to 'My Society' part of the website, select ‘Update my profile’, and then go to the tab ‘Committees & Groups’.